Please find enclosed Notice of 38th Annual General Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Limited has notified BSE about its 38th AGM scheduled for Tuesday, September 30, 2025, at 3:00 PM, to be held via video conferencing. Three items will be taken up: (1) adoption of the audited standalone and consolidated financial statements for FY ended March 31, 2025; (2) re-appointment of Dr. Sankaranarayanan Alangudi (Whole-time Director designated as CEO & President, aged 81, with over 42 years of pharma R&D experience) who retires by rotation; and (3) appointment of Mr. Vinay Babu Gade, Practicing Company Secretary, as the Secretarial Auditor for a five-year term from FY 2025-26 to FY 2029-30, at a remuneration of ₹75,000 plus taxes for FY 2025-26. Shareholders can vote remotely via CDSL e-voting between September 26 and September 29, 2025, with the cut-off date set as September 23, 2025. The deemed venue for the AGM is the company's registered office in Hyderabad.
This is a routine AGM notice with no major corporate actions like fundraising, M&A, or dividend declarations. Shareholders should review the proposed re-appointment of the CEO and the new secretarial auditor, and exercise their voting rights during the September 26-29 e-voting window.